全文获取类型
收费全文 | 25291篇 |
免费 | 1693篇 |
国内免费 | 597篇 |
专业分类
耳鼻咽喉 | 140篇 |
儿科学 | 484篇 |
妇产科学 | 399篇 |
基础医学 | 1800篇 |
口腔科学 | 268篇 |
临床医学 | 3370篇 |
内科学 | 7012篇 |
皮肤病学 | 102篇 |
神经病学 | 353篇 |
特种医学 | 696篇 |
外科学 | 7281篇 |
综合类 | 2960篇 |
现状与发展 | 1篇 |
预防医学 | 761篇 |
眼科学 | 255篇 |
药学 | 1186篇 |
17篇 | |
中国医学 | 223篇 |
肿瘤学 | 273篇 |
出版年
2024年 | 48篇 |
2023年 | 567篇 |
2022年 | 1020篇 |
2021年 | 1472篇 |
2020年 | 1449篇 |
2019年 | 1337篇 |
2018年 | 1267篇 |
2017年 | 867篇 |
2016年 | 792篇 |
2015年 | 889篇 |
2014年 | 1876篇 |
2013年 | 1794篇 |
2012年 | 1198篇 |
2011年 | 1417篇 |
2010年 | 1149篇 |
2009年 | 1154篇 |
2008年 | 1062篇 |
2007年 | 1024篇 |
2006年 | 967篇 |
2005年 | 850篇 |
2004年 | 717篇 |
2003年 | 628篇 |
2002年 | 544篇 |
2001年 | 442篇 |
2000年 | 389篇 |
1999年 | 322篇 |
1998年 | 275篇 |
1997年 | 241篇 |
1996年 | 222篇 |
1995年 | 195篇 |
1994年 | 184篇 |
1993年 | 159篇 |
1992年 | 152篇 |
1991年 | 95篇 |
1990年 | 92篇 |
1989年 | 84篇 |
1988年 | 86篇 |
1987年 | 92篇 |
1986年 | 74篇 |
1985年 | 72篇 |
1984年 | 68篇 |
1983年 | 45篇 |
1982年 | 55篇 |
1981年 | 28篇 |
1980年 | 30篇 |
1979年 | 30篇 |
1978年 | 16篇 |
1976年 | 15篇 |
1975年 | 9篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
Nirmanmoh Bhatia Buddhadeb Dawn Tariq S. Siddiqui Marcus F. Stoddard 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2015,42(1):16-24
Determining aortic stenosis (AS) severity is clinically important. Calculating aortic valve (AV) area by means of the continuity equation assumes a circular left ventricular outflow tract (LVOT). The full impact of this assumption in calculating AV area is unknown. Predictors of noncircular LVOT shape in patients with AS are undefined.In 109 adult patients with AS who underwent multiplanar transesophageal echocardiography, we calculated AV area by means of the standard continuity method and by a modified method involving planimetric LVOT area.We found 54 circular, 37 horizontal-oval, 8 vertical-oval, and 10 irregular LVOTs. Area derived by direct planimetry correlated better with the modified than the standard continuity method (r=0.89 vs r=0.85; both P=0.0001). Valve areas of patients with mild, moderate, or severe AS by planimetry were more often mischaracterized with use of the standard than modified method (29 vs 18; P <0.0001). Horizontal-oval AV area derived by planimetry (1.28 ± 0.55 cm2) was underestimated by the standard method (1.05 ± 0.47 cm2; P=0.001), but not by the modified method. Congenital AV morphology and low cardiac index were the only multivariate predictors of horizontal-oval shape. Low cardiac index was the only predictor of noncircular shape.More than half our patients with AS had noncircular LVOTs. Using the modified method reduces mischaracterizations of AS severity. Congenital AV morphology and low cardiac index predict horizontal-oval or noncircular shape. These data suggest the value of direct LVOT measurement to calculate AS severity in patients who have congenital AV or a low cardiac index. 相似文献
23.
24.
25.
26.
《Cancer cell》2021,39(11):1497-1518.e11
- Download : Download high-res image (282KB)
- Download : Download full-size image
27.
《Foot and Ankle Surgery》2022,28(7):883-886
BackgroundStudies concerning total ankle arthroplasty could be influenced by several forms of bias. Independent national arthroplasty registries represent objective data on survival and patient reported outcomes. The aim of this study was to determine survival and identify risk factors for early failure in a nationwide series of total ankle arthroplasties from the Dutch Arthroplasty Register (LROI).Patients and methodsData of 810 patients, who received 836 total ankle arthroplasties between 2014 and 2020 were obtained from the Dutch Arthroplasty Register (LROI) with a median follow-up of 38 months (range 1–84 months). Survival was expressed in Kaplan-Meier analysis and associated hazard ratios for implant failure were determined. Implant failure was defined as the need for revision surgery for any reason or (pan)arthrodesis.ResultsDuring follow-up, we recorded 39 failures (4.7%) resulting in a implant survival of 95.3% with a median follow-up of 38 months (range 1–84 months). Medial malleolus osteotomy (HR = 2.27), previous surgery (HR = 1.83), previous osteotomy (HR = 2.82) and previous ligament reconstruction (HR = 2.83) all showed potentially clinically meaningful associations with a higher incidence of implant failure, yet only previous OCD treatment (HR = 6.21), BMI (HR = 1.09) and age (HR = 0.71) were statistically significant.InterpretationExcellent short-term survival (95.3%) with a median follow-up of 38 months was reported for TAA patients from the Dutch Arthroplasty Register. Patients with a lower age, a higher BMI or who had a prior surgical OCD treatment before TAA surgery appear to have a higher risk for revision after short-term clinical follow-up. Thorough patient selection with emphasis on risk factors associated with early implant failure might be essential to improve TAA survivorship. 相似文献
28.
29.
《Revista espa?ola de anestesiología y reanimación》2022,69(9):517-525
Background and objectivesThe ideal timing of tranexamic acid administration in total knee arthroplasty with tourniquet remains unclear. Our primary objective was to prove if administering it before surgical incision, instead of before releasing the tourniquet, reduces postoperative bleeding. A second objective was to determine whether a second dose reduces post-operative bleeding.Material and methodsA prospective, double-blind clinical trial was performed on 212 patients scheduled for total knee arthroplasty. They were randomised into 4 groups. Tranexamic acid was administered before the surgical incision in “pre-induction groups” (1 and 2), and just before the tourniquet release in “pre-release groups” (3 and 4). Groups 2 and 4 received a second dose 3 hours post-surgery. Main outcome was postoperative bleeding (visible blood loss and calculated total bleeding). Secondary outcomes were haemoglobin variations, complications and transfusion rate.ResultsThe mean calculated total bleeding was 1563 ml (95%CI: 1445 to 1681) in preinduction groups versus 1576 ml (95%CI: 1439 to 1713) in pre-release groups (P = .9); 1579 ml (95%CI: 1452 to 1706) in single-dose groups versus 1559 ml (95%CI: 1431 to 1686) in double-dose groups (P = .82). One patient was transfused. The mean haemoglobin at discharge was 10.4 g/dl (95%CI: 10.2 to 10.7) in singledose groups versus 10.8 (95%CI: 10.6 to 11.1) in double-dose groups (P = .06).ConclusionsThere were no differences in bleeding or transfusion regarding the time of tranexamic acid administration. The second dose had not impact on outcomes.Trial registration: EudraCT 2016-000071-24. 相似文献
30.